Comparison of clinical outcome between high and low baseline anti-ABO antibody titers in ABO-incompatible kidney transplantation

Renal Failure

Volumn 33, Issue 2, 2011, Pages 150-158

  Chung, Byung Ha ^a   Lee, Ja Young ^a   Kang, Seok Hui ^a   Sun, In O ^a   Choi, Sun Ryoung ^a   Park, Hoon Suk ^a   Kim, Ji Il ^a   Moon, In Sung ^a   Choi, Bum Soon ^a   Park, Cheol Whee ^a   Kim, Yong Soo ^a   Yang, Chul Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Anti ABO antibody; kidney transplantation; plasmapheresis; rituximab

Indexed keywords

BASILIXIMAB; BLOOD GROUP ANTIBODY; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ABO INCOMPATIBLE KIDNEY TRANSPLANTATION; ACUTE GRAFT REJECTION; ADULT; ALLOGRAFT; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FOLLOW UP; GINGIVITIS; GRAFT FAILURE; HUMAN; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; OUTCOME ASSESSMENT; PLASMAPHERESIS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; VIREMIA;

ABO BLOOD-GROUP SYSTEM; ADULT; BIOPSY; FEMALE; HUMANS; ISOANTIBODIES; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79951971874     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.552149     Document Type: Article

References (20)

1. Korean Network for Organ Sharing. KONOS 2009 annual report. Available at www.konons.go.kr. Accessed August 21, 2010.
2. Huh KH, Kim MS, Ju MK, et al. Exchange living-donor kidney transplantation: Merits and limitations. Transplantation. 2008;86:430-435.
3. Hume DM, Merrill JP, Miller BF, Thorn GW. Experiences with renal homotransplantation in the human: Report of nine cases. J Clin Invest. 1955;34:327-382.
4. Alexandre GP, De Bruyere M, Squifflet JP, Moriau M, Latinne D, Pirson Y. Human ABO-incompatible living donor renal homografts. Neth J Med. 1985;28:231-234.
5. Rahman T, Harper L. Plasmapheresis in nephrology: An update. Curr Opin Nephrol Hypertens. 2006;15:603-609. (Pubitemid 44607432)
6. Montgomery RA. Renal transplantation across HLA and ABO antibody barriers: Integrating paired donation into desensitization protocols. Am J Transplant. 2010;10:449-457.
7. Tobian AA, Shirey RS, Montgomery RA, Tisch DJ, Ness PM, King KE. Therapeutic plasma exchange reduces ABO titers to permit ABO-incompatible renal transplantation. Transfusion. 2009;49:1248-1254.
8. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant. 2008;8:753-760. (Pubitemid 351347767)
9. Gloor JM, Lager DJ, Moore SB, et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation. 2003;75:971-977. (Pubitemid 36438524)
10. Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Takahashi K, Toma H. Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation. 2000;70:1331-1335.
11. Shimmura H, Tanabe K, Ishida H, et al. Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression. Transplantation. 2005;80:985-988. (Pubitemid 41552897)
12. Uchida J, Iwai T, Kato M, et al. A novel approach to successful ABO-incompatible high-titer renal transplantation. Transplant Proc. 2008;40:2285-2288.
13. Gloor JM, Lager DJ, Fidler ME, et al. A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation. 2005;80:1572-1577. (Pubitemid 43005868)
14. Vieira CA, Agarwal A, Book BK, et al. Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation. 2004;77:542-548. (Pubitemid 38282809)
15. Toki D, Ishida H, Horita S, Setoguchi K, Yamaguchi Y, Tanabe K. Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients. Transpl Int. 2009;22:447-454.
16. Setoguchi K, Ishida H, Shimmura H, et al. Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation. Am J Transplant. 2008;8:86-94.
17. Haas M, Segev DL, Racusen LC, et al. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol. 2009;20:197-204.
18. Shimmura H, Tanabe K, Tokumoto T, et al. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation. Transplant Proc. 2004;36:2172-2174. (Pubitemid 39424370)
19. Grim SA, Pham T, Thielke J, et al. Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients. Clin Transplant. 2007;21:628-632. (Pubitemid 47399427)
20. Aikawa A, Ohara T, Arai K, et al. Clinical outcome and accommodation in ABO incompatible kidney transplantation. Clin Transplant. 2004;1:135-142.